// April 25, 2023 | 18th Annual Huntington's Disease Therapeutics Conference Dubrovnik, Croatia

Allele-selective SNP editing utilizing AAV5-delivered Life Edit® nuclease and guide RNA resulting in meaningful reduction of mutant HTT protein